Philippe Degive

Vorstandsvorsitzender bei

Investsud SA

Health Technology

Finance

Consumer Services

Profil

Philippe Degive is currently the CEO at Investsud SA. He is also a Non-Executive Director at Ogeda SA, a Director at Bridge2Health SA, and an Investment Manager at Société Régionale d'Investissement de Wallonie SA since 2008.
Previously, he held positions as a Director at PROMETHERA Biosciences SA, iSTAR Medical SA, Novadip Biosciences SA, Pluriomics BV, and Ncardia SA. Mr. Degive obtained an MBA from the University of Liege in 1994.

Aktive Positionen von Philippe Degive

Unternehmen	Position	Beginn
Ogeda SA Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs	Direktor/Vorstandsmitglied	-
Bridge2Health SA Bridge2Health SA BiotechnologyHealth Technology Provides biomedical translational research services	Direktor/Vorstandsmitglied	-
Société Régionale d'Investissement de Wallonie SA Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance SRIW invests in companies located in Belgium. The firm focuses on a broad range of sectors. It participates in equity and debt in seed, early, later, growth, MBI & MBO transactions. The firm acquires majority interests for certain transactions.	Private Equity Investor	01.07.2008
Investsud SA Investsud SA Investment ManagersFinance INVESTSUD is an active manager which invests in family-owned small and medium-sized companies across the industrial, commercial and services sectors operating in the Belgian provinces of Liège, Namur or Luxembourg. They do not invest in failing companies. The firm seeks to invest EUR 0.1-3 million in companies with a quality project and significant profit potential. They typically take minority stakes and seek board representation, partnering with management to create value through a range of support activities including sourcing funding structures that provide maximum security to the shareholders, helping them out of isolation, preparing them for estate planning or assisting them in an investment or takeover plan.	Vorstandsvorsitzender	01.05.2023

Alle aktiven Positionen von Philippe Degive

Ehemalige bekannte Positionen von Philippe Degive

Unternehmen	Position	Ende
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Direktor/Vorstandsmitglied	06.04.2018
Ncardia SA Ncardia SA Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery research organization	Direktor/Vorstandsmitglied	-
Novadip Biosciences SA Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases	Direktor/Vorstandsmitglied	02.01.1901
Pluriomics BV Pluriomics BV BiotechnologyHealth Technology Research and development of pharmaceuticals	Direktor/Vorstandsmitglied	-
iSTAR Medical SA iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Philippe Degive im Detail an

Ausbildung von Philippe Degive

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Philippe Degive im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	10
Société Régionale d'Investissement de Wallonie SA Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance SRIW invests in companies located in Belgium. The firm focuses on a broad range of sectors. It participates in equity and debt in seed, early, later, growth, MBI & MBO transactions. The firm acquires majority interests for certain transactions.	Finance
Ogeda SA Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs	Health Technology
University of Liege University of Liege Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Investsud SA Investsud SA Investment ManagersFinance INVESTSUD is an active manager which invests in family-owned small and medium-sized companies across the industrial, commercial and services sectors operating in the Belgian provinces of Liège, Namur or Luxembourg. They do not invest in failing companies. The firm seeks to invest EUR 0.1-3 million in companies with a quality project and significant profit potential. They typically take minority stakes and seek board representation, partnering with management to create value through a range of support activities including sourcing funding structures that provide maximum security to the shareholders, helping them out of isolation, preparing them for estate planning or assisting them in an investment or takeover plan.	Finance
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Health Technology
Bridge2Health SA Bridge2Health SA BiotechnologyHealth Technology Provides biomedical translational research services	Health Technology
iSTAR Medical SA iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions	Health Technology
Novadip Biosciences SA Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases	Health Technology
Pluriomics BV Pluriomics BV BiotechnologyHealth Technology Research and development of pharmaceuticals	Health Technology
Ncardia SA Ncardia SA Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery research organization	Commercial Services